Publication Name	World Journal of Gastroenterology
Manuscript ID	8929
Country	Hungary

Received	2014-01-13 11:17
Peer-Review Started	2014-01-23 09:47
First Decision by Editorial Office Director
Return for Revision	2014-02-20 10:24
Revised	2014-03-12 02:32
Publication Fee Transferred
Second Decision by Editor	2014-04-23 09:28
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-04-23 10:22
Articles in Press	2014-05-23 10:23
Edit the Manuscript by Language Editor	2014-06-30 08:55
Typeset the Manuscript	2014-07-16 09:48
Publish the Manuscript Online	2014-08-07 10:34

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Randomized Controlled Trial
Article Title	Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis?
Manuscript Source	Unsolicited Manuscript
All Author List	Zoltán Döbrönte, Zoltán Szepes, Ferenc Izbéki, Judit Gervain, László Lakatos, Gyula Pécsi, Miklós Ihász, Lilla Lakner, Erzsébet Toldy and László Czakó
Funding Agency and Grant Number	Funding Agency Grant Number TÁMOP-4.2.2.A-11/1/KONV 2012-0035 OTKA K101521
Corresponding Author	László Czakó, MD, PhD, 1st Department of Medicine, University of Szeged, Dugonics tér, P.O.Box: 427, 6701 Szeged, Hungary. czako.laszlo@med.u-szeged.hu
Key Words	Endoscopic retrograde cholangiopancreatography; Post-endoscopic retrograde cholangiopancreatography pancreatitis; Hyperamylasaemia; Non-steroidal anti-inflammatory drugs; Indomethacin
Core Tip	Acute pancreatitis is the most common and potentially fatal complication of endoscopic retrograde cholangiopancreatography (ERCP). Non-steroidal anti-inflammatory drugs have been suggested to be effective in prospective controlled trials, but the results are inconclusive. A prospective, randomised, placebo-controlled multicentre study was therefore conducted in five endoscopic units. The results for 665 patients who randomly received a suppository containing 100 mg indomethacin or placebo before ERCP were evaluated. There was no difference between the indomethacin and placebo groups in the incidence of either post-ERCP pancreatitis or hyperamylasaemia. Rectal indomethacin is not effective in preventing post-ERCP pancreatitis in average-risk patients.
Publish Date	2014-08-07 10:34
Citation	Döbrönte Z, Szepes Z, Izbéki F, Gervain J, Lakatos L, Pécsi G, Ihász M, Lakner L, Toldy E, Czakó L. Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis? World J Gastroenterol 2014; 20(29): 10151-10157
URL	http://www.wjgnet.com/1007-9327/full/v20/i29/10151.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i29.10151

Full Article (PDF)	WJG-20-10151.pdf
Full Article (Word)	WJG-20-10151.doc
Manuscript File	8929-Review.docx
Answering Reviewers	8929-Answering reviewers.pdf
Biostatistics Review Certificate	Biostatistician_Review_Report_20140112061356.pdf
Copyright License Agreement	8929-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	Ethics_Committee_20140112061615.pdf
Non-Native Speakers of English Editing Certificate	8929-Language certificate.pdf
Peer-review Report	8929-Peer reviews.pdf
Scientific Editor Work List	8929-Scientific editor work list.doc